Gladstone NOW: The Campaign Join Us on the Journey ✕
31 - 45 of 51 Results Clear All
Gladstone scientists uncover new gatekeeper function of anti-aging molecule
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Mucke Lab Aging
Transplanting a special type of neuron into the brain restores cognitive functions in Alzheimer’s models
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Mucke Lab Palop Lab
Gladstone scientists receive funding to develop new drugs to reduce tau levels in the brain
Assay Development and Drug Discovery Core Alzheimer’s Disease Mucke Lab
In a meeting of the minds, Gladstone hosted a national behavioral neuroscience symposium to share scientific breakthroughs and compare research methods.
Behavioral Core Mucke Lab
Gladstone scientists discover how to control the cacophony of electrical activity in the brain, stopping seizures and reducing deficits related to Alzheimer’s disease.
Alzheimer’s Disease Epilepsy Mucke Lab Paz Lab Optogenetics
Scientists at the Gladstone Institutes take a comprehensive approach to dementia research, pursuing several potential causal factors of the disease in the hopes of discovering breakthrough treatments.
Alzheimer’s Disease Gan Lab Huang Lab Mucke Lab
Sumihiro Maeda, a research scientist at Gladstone, shares how his curiosity about where imagination and creativity come from led his path to study Alzheimer's disease.
Mucke Lab
New findings about Alzheimer’s disease advance the search for more effective treatments.
Alzheimer’s Disease Mucke Lab
Researchers from the Gladstone Institutes have shown for the first time that the protein BRCA1 is required for normal learning and memory and is depleted by Alzheimer’s disease.
Mucke Lab Alzheimer’s Disease
Hear Lennart Mucke, MD, Director of the Gladstone Institute of Neurological Disease, discuss progress towards Alzheimer’s cures during his recent City Arts & Lectures appearance.
Mucke Lab Alzheimer’s Disease
Raising levels of the life-extending protein klotho can protect against learning and memory deficits in a mouse model of Alzheimer’s disease, despite the accumulation of Alzheimer-related toxins in the brain.
Mucke Lab Aging Alzheimer’s Disease
SAN FRANCISCO, CA—Researchers at the Gladstone Institutes have shown that reducing brain levels of the protein tau effectively blocks the development of disease in a mouse model of Dravet syndrome, a severe intractable form of childhood epilepsy.
Epilepsy Mucke Lab
A joint Gladstone-UCSF study reveals a gene linked to longevity also improves learning and memory. This discovery opens a new path for treating Alzheimer's and other aging-related diseases.
Research (Publication) Alzheimer’s Disease Mucke Lab Aging
SAN FRANCISCO, CA—Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, next week will receive the ARCS Foundation’s 2013 Pacesetter Award for his lifelong dedication to overcoming Alzheimer’s disease—and for mentoring students to take a similar approach.
Mucke Lab Neurological Disease Alzheimer’s Disease
SAN FRANCISCO, CA—Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, today received the MetLife Foundation’s 2013 Award for Medical Research in Alzheimer’s Disease at a scientific briefing and awards ceremony in New York.
Alzheimer’s Disease Mucke Lab
